{
    "organizations": [],
    "uuid": "86d8c75f7d8cff076a9413a506779698cd5b5fd8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hangzhou-tianmushan-pharmaceutical/brief-hangzhou-tianmushan-pharmaceutical-enterprise-sees-fy-2017-net-profit-up-1872-pct-to-2364-pct-idUSL4N1PR3MX",
    "ord_in_thread": 0,
    "title": "BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise sees FY 2017 net profit up 1,872 pct to 2,364 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1(Reuters) - Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd :\n* Sees FY 2017 net profit to increase by 1,872 percent to 2,364 percent, or to be 24 million yuan to 30 million yuan\n* Says FY 2016 net profit was 1.2 million yuan\n* The reasons for the forecast are production recovery and assets disposal Source text in Chinese: goo.gl/KB7KhH Further company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-01T17:52:00.000+02:00",
    "crawled": "2018-02-02T12:59:20.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "hangzhou",
        "tianmushan",
        "pharmaceutical",
        "enterprise",
        "co",
        "ltd",
        "see",
        "fy",
        "net",
        "profit",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "net",
        "profit",
        "million",
        "yuan",
        "reason",
        "forecast",
        "production",
        "recovery",
        "asset",
        "disposal",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}